In low-grade glioma, the expression level of transforming growth factor beta 1 (TGF-β) and programmed cell death ligand 1 (PDL1) was positively correlated with immune risk score, and prognostic hub genes that were positively correlated with immune cell infiltration have also been revealed (25, 26). The gene discussed is TGFB1; the disease is central nervous system cancer.